Title | Retinoid X receptor gamma signaling accelerates CNS remyelination. |
Publication Type | Journal Article |
Year of Publication | 2011 |
Authors | Huang JK, Jarjour AA, Oumesmar BNait, Kerninon C, Williams AC, Krezel W, Kagechika H, Bauer J, Zhao C, Van Evercooren ABaron-, Chambon P, ffrench-Constant C, Franklin RJM |
Journal | Nat Neurosci |
Volume | 14 |
Issue | 1 |
Pagination | 45-53 |
Date Published | 2011 Jan |
ISSN | 1546-1726 |
Keywords | Aged, Animals, Benzoates, Biphenyl Compounds, Cell Differentiation, Cell Lineage, Cells, Cultured, Central Nervous System, Cerebellum, Demyelinating Diseases, Female, Gene Expression Profiling, Humans, Male, Mice, Mice, Knockout, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Regeneration, Neurotoxins, Oligodendroglia, Rats, Rats, Sprague-Dawley, Receptors, Retinoic Acid, RNA Interference, Stem Cells, Tretinoin |
Abstract | The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-γ were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-γ in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-γ by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-γ, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS. |
DOI | 10.1038/nn.2702 |
Alternate Journal | Nat. Neurosci. |
PubMed ID | 21131950 |
PubMed Central ID | PMC4013508 |
Grant List | 089000 / / Wellcome Trust / United Kingdom G0701476 / / Medical Research Council / United Kingdom / / Wellcome Trust / United Kingdom |